Motley Fool's Promotional Article on Pagaya Contrasts with DeepValue's Risk-Focused Analysis

What happened

On March 3, 2026, The Motley Fool published an article recommending Pagaya as an AI stock to buy and hold, highlighting its use of AI in loan processing and a strategic pivot that has temporarily hurt revenue. According to the latest DeepValue master report, Pagaya has demonstrated Network Volume growth and continued ABS market access, such as the upsized PAID 2026-1 deal at $800M with 32 investors. However, the report reveals underlying pressures, including negative capital markets execution fees in Q4 and FY2025 and a recent increase in allowance for credit losses, signaling spread and credit risks. The article's optimistic portrayal overlooks structural vulnerabilities like funding concentration, mandatory risk retention, and sensitivity to ABS pricing, which the report quantifies as a 100 bps discount reducing upfront fees by ~$10M. Consequently, DeepValue maintains a WAIT rating, emphasizing the need for observable proof of positive execution fees and stable credit reserves before investment.

Implication

The Motley Fool article may draw retail interest, but it glosses over critical financial weaknesses documented in SEC filings, such as negative execution fees and rising credit reserves that threaten profitability. Pagaya's growth is contingent on favorable ABS spreads, yet recent data shows fee compression, with management acknowledging that pricing shifts directly impact upfront revenue. Structural issues like concentrated funding sources and 5% risk retention exacerbate volatility, making the stock susceptible to market downturns without a margin of safety. Investors must monitor upcoming quarterly results for signs of positive execution fees and stable allowances, as these are key indicators for any thesis upgrade. Until then, maintaining a WAIT stance is prudent to avoid capital impairment from persistent spread pressure or credit deterioration.

Thesis delta

The new article confirms the revenue impact from Pagaya's strategic pivot, aligning with the report's observation of temporary earnings pressure. However, it fails to address the depth of capital markets and credit risks, reinforcing that no shift in the investment thesis is warranted. The WAIT rating remains appropriate, pending evidence from future filings that execution fees have turned positive and credit reserves have stabilized.